ZA893517B - Peptide-drug compositions containing alpha-aminoboronic acid derivatives - Google Patents

Peptide-drug compositions containing alpha-aminoboronic acid derivatives

Info

Publication number
ZA893517B
ZA893517B ZA893517A ZA893517A ZA893517B ZA 893517 B ZA893517 B ZA 893517B ZA 893517 A ZA893517 A ZA 893517A ZA 893517 A ZA893517 A ZA 893517A ZA 893517 B ZA893517 B ZA 893517B
Authority
ZA
South Africa
Prior art keywords
peptide
compositions containing
acid derivatives
drug compositions
containing alpha
Prior art date
Application number
ZA893517A
Other languages
English (en)
Inventor
Munir Alwan Hussain
Alwan Hussain Munir
Ashokkumar Bhikkappa Shenvi
Bhikkappa Shenvi Ashokkumar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of ZA893517B publication Critical patent/ZA893517B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA893517A 1988-05-11 1989-05-11 Peptide-drug compositions containing alpha-aminoboronic acid derivatives ZA893517B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19269088A 1988-05-11 1988-05-11

Publications (1)

Publication Number Publication Date
ZA893517B true ZA893517B (en) 1991-01-30

Family

ID=22710674

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA893517A ZA893517B (en) 1988-05-11 1989-05-11 Peptide-drug compositions containing alpha-aminoboronic acid derivatives

Country Status (13)

Country Link
EP (1) EP0341661A3 (fi)
JP (1) JPH01319428A (fi)
KR (1) KR900017581A (fi)
AU (1) AU616968B2 (fi)
DK (1) DK229089A (fi)
FI (1) FI892254A (fi)
HU (1) HUT51144A (fi)
IL (1) IL90244A (fi)
MY (1) MY104088A (fi)
NO (1) NO891926L (fi)
NZ (1) NZ229053A (fi)
PT (1) PT90519B (fi)
ZA (1) ZA893517B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673376A1 (fr) * 1991-03-01 1992-09-04 Lefesvre Andre Composition pharmaceutique pour le traitement des tumeurs de kaposi.
JPH06510796A (ja) * 1991-12-18 1994-12-01 ファイザー　インク． 酵素による不活性化から生物活性ペプチドを保護するための医薬組成物におけるダイズタンパク質又は加水分解物
US6153592A (en) * 1992-11-09 2000-11-28 Port Systems, Llc Enhancing the bioavailability of proteolytically labile therapeutic agents
US7097839B1 (en) 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
MXPA05002662A (es) 2002-09-09 2005-09-20 Trigen Ltd Sales de metal multivalente de acidos boronicos para el tratamiento de trombosis.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537773A (en) * 1983-12-05 1985-08-27 E. I. Du Pont De Nemours And Company α-Aminoboronic acid derivatives
US4499082A (en) * 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
DE3840452A1 (de) * 1988-12-01 1990-06-07 Hoechst Ag (beta)-amino-boronsaeure-derivate

Also Published As

Publication number Publication date
NO891926L (no) 1989-11-13
HUT51144A (en) 1990-04-28
IL90244A0 (en) 1989-12-15
AU3468289A (en) 1989-11-16
FI892254A (fi) 1989-11-12
JPH01319428A (ja) 1989-12-25
AU616968B2 (en) 1991-11-14
PT90519B (pt) 1994-10-31
EP0341661A2 (en) 1989-11-15
DK229089D0 (da) 1989-05-10
KR900017581A (ko) 1990-12-19
MY104088A (en) 1993-11-30
NZ229053A (en) 1990-12-21
IL90244A (en) 1993-05-13
NO891926D0 (no) 1989-05-11
FI892254A0 (fi) 1989-05-10
PT90519A (pt) 1989-11-30
EP0341661A3 (en) 1991-05-02
DK229089A (da) 1989-11-12

Similar Documents

Publication Publication Date Title
EP0363748A3 (en) Oral compositions
GB8808305D0 (en) Compositions
GB8811830D0 (en) Oral compositions
GB8904454D0 (en) Oral compositions
PH25851A (en) Oral compositions
GB8811828D0 (en) Oral compositions
GB8811829D0 (en) Oral compositions
IL92497A0 (en) Beta-amino-boronic acid derivatives
AR243379A1 (es) Composiciones orales que proveen una absorcion eficaz de fluoruro por parte del esmalte dental.
GB8728675D0 (en) Compounds & compositions
ZA898598B (en) Oral compositions
GB8804457D0 (en) Compositions
GB8827899D0 (en) Compound composition process & use
GB8815593D0 (en) Compositions
GB8813144D0 (en) Compositions
IL87494A0 (en) Pharmaceutical compositions containing benzylpyrimidine derivatives
GB8811616D0 (en) Compositions
ZA893517B (en) Peptide-drug compositions containing alpha-aminoboronic acid derivatives
IL86437A0 (en) Pharmaceutical compositions containing certain pyranoquinoline derivatives
EP0421752A3 (en) Substituted acrylamido-penicillanic acid derivatives
GR3000526T3 (en) Therapeutical compositions containing benzhydryl thiomethane derivatives
GB2206491B (en) Anti-anxiogenic compositions containing dioxopiperidine derivatives
IL89049A0 (en) Pharmaceutical composition containing 4-aroylimidazol-2-ones
ZW13589A1 (en) Panicillanic acid derivatives
IL84857A0 (en) Pharmaceutical compositions containing certain pyranoquinoline derivatives